Company Data
Nektar Therapeutics
Ticker
NKTR
Current Price
$25.01 -0.36%
Market Cap
$310.3M
Price Target
Refer to Report
Volume
1.2M
52wk Range
$6.48 - $37.38
Overview
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama, and Hyderabad, India.